Drawing for ALRIVSY

USPTO serial 87411881

ALRIVSY

Reviewed by CopyMark Law Group

Reg. 6182383Status 700Renewal
Filing date
Status date
Registration date
Oct 27, 2020
Examiner
HENRY, NAKIA D
Law office
TMO LAW OFFICE 129 - EXAMINING ATTORNEY ASSIGNED

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ALRIVSY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $425

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Shelley Lai

Shelley Lai Gilead Sciences, Inc.333 Lakeside DriveFoster City, CA 94404United States

Goods and services

ClassDescriptionStatusFirst use
005Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritisACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 22, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 22, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 22, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 22, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 22, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 27, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 11, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 11, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 11, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 11, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 11, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 27, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 23, 2020DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Sep 22, 2020IUCNNOTICE OF ALLOWANCE CANCELLED—
Sep 22, 2020D1BRTEAS DELETE 1(B) BASIS RECEIVED—
Mar 26, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 25, 2020EX5GSOU EXTENSION 5 GRANTED—
Mar 23, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 18, 2020EXT5SOU EXTENSION 5 FILED—
Mar 18, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 26, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 24, 2019EX4GSOU EXTENSION 4 GRANTED—
Sep 24, 2019EXT4SOU EXTENSION 4 FILED—
Sep 24, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 21, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 19, 2019EX3GSOU EXTENSION 3 GRANTED—
Mar 19, 2019EXT3SOU EXTENSION 3 FILED—
Mar 19, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 15, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 13, 2018EX2GSOU EXTENSION 2 GRANTED—
Sep 13, 2018EXT2SOU EXTENSION 2 FILED—
Sep 13, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 17, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 15, 2018EX1GSOU EXTENSION 1 GRANTED—
Mar 15, 2018EXT1SOU EXTENSION 1 FILED—
Mar 15, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 21, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 26, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 26, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 6, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 22, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 21, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 21, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 20, 2017ALIEASSIGNED TO LIE—
Jul 27, 2017ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jul 10, 2017GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jul 10, 2017GNSLLETTER OF SUSPENSION E-MAILED—
Jul 10, 2017CNSLSUSPENSION LETTER WRITTEN—
Jul 10, 2017DOCKASSIGNED TO EXAMINER—
Apr 21, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 18, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance